Targeted Probiotics There is a focus on precisely targeted probiotic strains with clinically validated efficacy, suggesting potential for co-marketing or white-label partnerships with wellness retailers and clinics seeking evidence-based probiotic offerings.

Clinical Evidence Products are described as evidence-based with ingredients and dosages aligned to clinical research, presenting an opportunity to position as a scientifically-supported premium probiotic line to healthcare providers and supplement distributors.

Product Innovation Biolever drinkable probiotics indicate a consumer-friendly delivery format and potential for partnerships with beverage brands, fitness studios, or direct-to-consumer platforms emphasizing convenience and adherence.

Early Stage Growth With revenue currently in the 0-1M range and a very small team, there is room to scale through B2B channels such as wellness retailers, clinics, and contract manufacturers, leveraging white-label or co-branding opportunities.

Strategic Positioning Industry peers in the wellness and probiotic space show strong market activity; Nature Major can pursue competitive positioning through clinical credibility, targeted strains, and potential partnerships to accelerate market entry and distribution reach.